drugset / Trial / NCT05913310
Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate efficacy and safety of Kui-Yuan chewable tablets in patients with hyperuricemia.
Timeline
- Start
- 2023-07
- Primary completion
- 2024-07
- Completion
- 2024-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Kui-Yuan Chewable Tablets | Unknown | — | — |
Indications
No indication recorded.